There are 2789 resources available
1308P - Efficacy and safety of anti-PD-1 therapy plus anlotinib in previously treated advanced NSCLC
Presenter: Xin Lv
Session: ePoster Display
1309P - A multicenter phase I study of radium-223 (Ra-223) plus pembrolizumab in patients with stage IV non-small cell lung cancer (NSCLC)
Presenter: Martin Reck
Session: ePoster Display
1398P - The impact of personalized prehabilitation on tolerance to chemotherapy in patients with gastric and oesophageal cancer. A controlled study
Presenter: Grigorios Christodoulidis
Session: ePoster Display
1399P - Risk factors for body weight loss after gastrectomy for gastric cancer analysed from the JCOG1001 phase III trial
Presenter: Takanobu Yamada
Session: ePoster Display
1400P - Initial symptoms and their association with survival in patients with stage II-III gastroesophageal adenocarcinoma
Presenter: Hannah Christina Puhr
Session: ePoster Display
1314P - Preliminary results of sequential combination of immunotherapy followed by chemotherapy in advanced non-small cell lung cancer
Presenter: Luc Heraudet
Session: ePoster Display
1315P - Impact of high fasting plasma glucose in the clinical outcome of patients with advanced NSCLC with PD-L1 ≥ 50% treated with frontline pembrolizumab
Presenter: Sandra Llop Serna
Session: ePoster Display
1317P - Renal toxicity in black patients with non-squamous non-small cell lung cancer treated with combination platinum-pemetrexed-pembrolizumab therapy
Presenter: Nino Balanchivadze
Session: ePoster Display